Oppening
08.00-09.00 | Registration |
09.00-09.10 | Opening |
Session I – Chairmen: Elissaveta Naumova, Amal Bishara
09.10-09.40 | Interpretation of GWAS findings in transplant outcome studies Mehmet Tevfik DORAK, Liverpool, United Kingdom |
09.40-9.55 | Role of H&I laboratory in Cord blood transplantation – standards, accreditation and beyond Elissaveta Naumova, Sofia, Bulgaria |
9.55-10.10 | The role of non-HLA genes in HSCT outcome Katerina Tarassi, Athens,Greece |
10.10-10.25 | HLA and KIR gene analysis as a predictive tool for the HSCT outcome Svetlana Vojvodić, Novi Sad, Serbia |
10.25-10.40 | Unrelated Stem Cell Transplantation – novel cell therapy in the treatment of heme malignancies in Clinical Institute „Fundeni” Daniel Coriu, Bucharest, Romania |
10.40-11.10 | Coffee break |